CA
SGYP

CapWealth Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

CapWealth Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,000
Closed -$11K – 287
2016
Q3 		$11K Hold
2,000
– – ﹤0.01% 212
2016
Q2 		$8K Hold
2,000
– – ﹤0.01% 220
2016
Q1 		$6K Hold
2,000
– – ﹤0.01% 274
2015
Q4 		$11K Hold
2,000
– – ﹤0.01% 193
2015
Q3 		$11K Hold
2,000
– – ﹤0.01% 193
2015
Q2 		$17K Hold
2,000
– – ﹤0.01% 179
2015
Q1 		$9K Buy
+2,000
New +$6.5K ﹤0.01% 224
2014
Q4 		– Sell
-2,000
Closed -$6K – 313
2014
Q3 		$6K Hold
2,000
– – ﹤0.01% 282
2014
Q2 		$8K Hold
2,000
– – ﹤0.01% 262
2014
Q1 		$11K Sell
2,000
-28
-1% -$157 ﹤0.01% 245
2013
Q4 		$11K Hold
2,028
– – ﹤0.01% 256
2013
Q3 		$9K Hold
2,028
– – ﹤0.01% 317
2013
Q2 		$9K Buy
+2,028
New +$10.2K ﹤0.01% 302

Other funds holding SGYP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

CapWealth Advisors's SGYP Position: Q4 2016 in Review

CapWealth Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2016, closing a stake of 2,000 shares — an estimated $11K sold.

CapWealth Advisors first reported a position in SGYP in Q2 2013 and held it in 13 quarters. The position peaked at $17K in Q2 2015. 156 funds tracked by Wall St. Rank hold SGYP as of Q4 2016.

  • CapWealth Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2016 after selling out during the quarter.
  • CapWealth Advisors sold 2,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2016, an estimated $11K.
  • CapWealth Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 13 quarters.
  • CapWealth Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $17K in Q2 2015.
  • 156 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2016.

Based on CapWealth Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.